OPHTHALMIC FORMULATION CONTAINING LOTEPREDNOL ETABONATE FOR TREATMENT OF DRY EYE

摘要

This invention relates to formulations for topical use comprising a steroid in combination with electrolytes, synthetic glycoproteins, synthetic proteins, synthetic enzymes and/or synthetic peptides in both a preservative and preservative free formulation/system for the treatment of dry eye and attendant inflammation.